CLEVELAND, July 12, 2011 /PRNewswire/ — Magellan Biosciences, a
global manufacturer of products designed to make diagnostic testing
easier, more cost-effective, and less labor intensive, announced
the FDA clearance of its new TREK Diagnostic Systems-brand
Sensititre AIM Automated Inoculation Delivery System for use with
all Sensititre dried plates. The small-footprint Sensititre AIM
System quickly and accurately doses microtitre plates, eliminating
both skipped wells and costly repeat tests, to improve laboratory
workflow and speed results to busy clinicians.
(Logo:
http://photos.prnewswire.com/prnh/20110411/NE81210LOGO)
The Sensititre AIM System’s compact, user-friendly design is
ideal for use directly on the benchtop or under a microbiology
safety cabinet, providing flexible storage and accessibility and
conserving valuable laboratory space. The easy-to-use, icon-driven
touch screen facilitates quick selection of dosing volumes and
patterns for simple, intuitive operation.
According to Magellan President and Chief Executive Officer
Hiroshi Uchida, Ph.D., “The goal of the new Sensititre AIM System
and all of our IVD susceptibility products is to make it easier for
clinicians to accurately determine the right combination of
antimicrobics to fight infection and the emerging problem of drug
resistance. Over the past two years, we have extended our portfolio
of FDA-cleared products, including the latest FDA-cleared
antimicrobics to provide a unique system that improves workflow and
reduces costs.
“Systems that perform accurately while providing faster results
are an obvious choice for busy laboratorians, but limited space for
new instrumentation is a major concern. With the new Sensititre AIM
System, laboratorians can conserve benchtop space and enhance
workflow without sacrificing the accuracy they demand in plate
inoculation,” Dr. Uchida continued.
The AIM System has been used successfully in veterinary and
pharmaceutica
‘/>”/>
